VIDEO: Device offers early promising results in monitoring IOP outside clinic

BySavas Komban

ByEamon N. Dreisbach

Fact checked byChristine Klimanskis, ELS

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Savas Komban, CEO and co-founder of Smartlens, discusses developments in unmet needs in glaucoma, including IOP assessment.

“One of the biggest problems in this space is that we are not able to assess IOP well enough in order to optimize the treatments,” he said. “The only treatable risk factor for glaucoma is elevated IOP — high eye pressure. Currently, there is no way to measure IOP outside the clinic. At Smartlens, we have been building technologies like miLens that will enable us to monitor IOP during patients’ daily routines.”

Published by:

Sources/Disclosures

Collapse

Source:

Komban S. Smartlens, Inc. Presented at: Glaucoma 360 New Horizons Forum; Feb. 3, 2023; San Francisco.

Disclosures: Komban reports being the CEO and co-founder of Smartlens.

Glaucoma 360 New Horizons Forum

Read more

VIDEO: Device offers early promising results in monitoring IOP outside clinic

Related Content